Precautions and Warnings With Ipratropium HFA Inhaler

Precautions and warnings with ipratropium HFA inhaler should be reviewed with your healthcare provider and fully understood before starting treatment. For example, you should know that the medication may make glaucoma, bladder problems, or breathing problems worse. Precautions and warnings with ipratropium HFA inhaler also include the possibility of allergic reactions and the potential for drug interactions.

The Ipratropium HFA Inhaler: What Should I Tell My Healthcare Provider?

You should talk with your healthcare provider prior to taking the ipratropium HFA inhaler (Atrovent® HFA) if you have:
 
Also, let your healthcare provider know if you are:
 
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
     
Make sure to tell your healthcare provider about all of the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.
 

Specific Precautions and Warnings With Ipratropium HFA Inhaler

Warnings and precautions to be aware of prior to using the ipratropium HFA inhaler include the following:
 
  • The ipratropium HFA inhaler is an anticholinergic medication. As with all anticholinergic medications, the ipratropium HFA inhaler can worsen glaucoma, bladder problems, and prostate problems. Talk to your healthcare provider before using the drug if you have any of these problems.
     
  • The ipratropium HFA inhaler is not a fast-acting medication and cannot replace fast-acting rescue inhalers. Tell your healthcare provider if the drug is not adequately controlling your breathing problems.
     
  • Sometimes, inhaled medications (including the ipratropium HFA inhaler) can make breathing problems worse. Tell your healthcare provider if the medication seems to make your breathing problems worse.
     
  • Contact your healthcare provider immediately if you have any vision or eye changes while using the drug.
     
  • The ipratropium HFA inhaler can interact with other medications (see Atrovent Drug Interactions).
     
  • The ipratropium HFA inhaler is considered a pregnancy Category B medication. This means that it is probably safe to use during pregnancy, although the full risks are not known. Talk to your healthcare provider about the risks and benefits of using the drug while pregnant (see Atrovent and Pregnancy).
     
  • It is not known if ipratropium HFA passes through breast milk. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider prior to using the drug (see Atrovent and Breastfeeding).
     

Ipratropium HFA Inhaler Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.